Covishield in open market after March-April: Serum Institute of India

Published: 01st December 2020 06:12 PM  |   Last Updated: 01st December 2020 06:16 PM  

The Pune-based #SerumInstituteofIndia (SII) could make the #Covid19 vaccine by AstraZeneca-Oxford University available in India’s market after March-April next year, the company has told this newspaper. SII is the manufacturing partner for #Covishield and is also sponsoring phase 2, 3 trial of the vaccine on 1,600 volunteers.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp